Table 1 Clinical characteristics of included studies between male and female
Reference | Number of patients | Incidence of lymphatic metastases | Incidence of distant metastases | Stage I/II (III/IV) | Overall survival | |||||
|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | |
Rao et al. [20] | 9 | 8 | 1/3 | 0/4 | 1/1 | 0/1 | 2/7 | 4/4 | -- | -- |
Hodge et al. [21] | 7 | 12 | -- | -- | -- | -- | -- | -- | -- | -- |
Altinok et al. [10] | 3 | 3 | 2/3 | 1/3 | -- | -- | 1/2 | 2/3 | 0/3 | 0/3 |
Zou et al. [22] | 5 | 4 | 2/5 | 1/4 | 1/5 | 0/4 | 3/2 | 1/3 | 3/4 | 3/4 |
Hung et al. [13] | 1 | 7 | 0/1 | 2/7 | 0/1 | 2/7 | 1/0 | 3/4 | -- | -- |
Green et al. [18] | 10 | 21 | 0/0 | 4/5 | 1/1 | 3/4 | 4/6 | 9/12 | -- | -- |
Zhong et al. [16] | 0 | 6 | -- | -- | -- | 5/6 | -- | -- | -- | -- |
Choueiri et al. [11] | 3 | 12 | -- | -- | -- | -- | -- | -- | -- | -- |
Pflueger et al. [19] | 4 | 12 | 1/2 | 3/4 | 1/1 | 0/3 | -- | 1/3 | -- | -- |
Gaillot-Durand et al. [17] | 0 | 2 | -- | -- | -- | -- | -- | -- | -- | -- |
Zhong et al. [12] | 0 | 4 | -- | -- | -- | -- | -- | -- | -- | -- |
Klatte et al. [4] | 1 | 1 | 1/1 | 0/1 | 1/1 | 0/1 | 0/1 | 1/0 | 0/1 | 0/1 |
Sukov et al. [15] | 2 | 4 | -- | 1/2 | 0/2 | 1/4 | -- | -- | 2/2 | 2/4 |
Kim et al. [14] | 4 | 0 | -- | -- | -- | -- | -- | -- | -- | -- |
Argani et al. [23] | 0 | 2 | -- | -- | -- | -- | -- | -- | -- | -- |